| 51 |
26045286 | Acute Invasive Pulmonary Aspergillosis Complicating Allergic Bronchopulmonary Aspergillosis: Case Report and Systematic Review. | 2015 Oct |
1 |
| 52 |
26184414 | Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease. | 2015 Sep |
1 |
| 53 |
26736983 | A semi-mechanistic pharmacokinetic model of saquinavir combined with itraconazole in HIV-1-positive patients. | 2015 |
1 |
| 54 |
26736984 | Pharmacokinetic model for the inhibition of simvastatin metabolism by itraconazole. | 2015 |
1 |
| 55 |
24405193 | Longitudinal monitoring of CYP3A activity in patients receiving 3 cycles of itraconazole pulse therapy for onychomycosis. | 2014 Apr |
4 |
| 56 |
24484539 | Comparison of catalytic properties of cytochromes P450 3A4 and 3A5 by molecular docking simulation. | 2014 |
2 |
| 57 |
25106415 | Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1. | 2014 Nov |
2 |
| 58 |
25216238 | Liver injury associated with ketoconazole: review of the published evidence. | 2014 Dec |
1 |
| 59 |
25359648 | Vitamin and mineral supplements: friend or foe when combined with medications? | 2014 Nov |
1 |
| 60 |
25429674 | Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450. | 2014 |
4 |
| 61 |
23139378 | Analysis of the repaglinide concentration increase produced by gemfibrozil and itraconazole based on the inhibition of the hepatic uptake transporter and metabolic enzymes. | 2013 Feb |
1 |
| 62 |
23462027 | Colchicine-antimicrobial drug interactions: what pharmacists need to know in treating gout. | 2013 Mar |
1 |
| 63 |
24114622 | Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. | 2013 Oct |
1 |
| 64 |
21838784 | CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast. | 2012 Feb |
1 |
| 65 |
22106171 | Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals. | 2012 Mar |
5 |
| 66 |
20400651 | Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren. | 2011 Mar |
1 |
| 67 |
21142269 | Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study. | 2011 |
1 |
| 68 |
21147222 | Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. | 2011 Feb |
1 |
| 69 |
21212239 | Comparison of the inhibitory profiles of itraconazole and cimetidine in cytochrome P450 3A4 genetic variants. | 2011 Apr |
3 |
| 70 |
21219398 | 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. | 2011 Feb |
1 |
| 71 |
21360715 | Pharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteers. | 2011 Apr |
1 |
| 72 |
21410294 | Pharmacokinetic drug interactions with vandetanib during coadministration with rifampicin or itraconazole. | 2011 |
2 |
| 73 |
21490593 | Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo. | 2011 Jun |
1 |
| 74 |
21716267 | Exposure to oral S-ketamine is unaffected by itraconazole but greatly increased by ticlopidine. | 2011 Aug |
1 |
| 75 |
21771587 | Drug interaction of (S)-warfarin, and not (R)-warfarin, with itraconazole in a hematopoietic stem cell transplant recipient. | 2011 Oct 9 |
1 |
| 76 |
21832990 | Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study. | 2011 Oct |
1 |
| 77 |
20000889 | Semi-mechanistic population pharmacokinetic drug-drug interaction modelling of a long half-life substrate and itraconazole. | 2010 |
1 |
| 78 |
20076952 | Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone. | 2010 Apr |
1 |
| 79 |
20497744 | Pharmacokinetic modeling of the dosing interval dependency for the interaction between itraconazole and triazolam. | 2010 Jun |
2 |
| 80 |
20575631 | Drug interaction between itraconazole and bortezomib: exacerbation of peripheral neuropathy and thrombocytopenia induced by bortezomib. | 2010 Jul |
1 |
| 81 |
20642550 | Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone. | 2010 Jul |
1 |
| 82 |
20739919 | Accurate prediction of dose-dependent CYP3A4 inhibition by itraconazole and its metabolites from in vitro inhibition data. | 2010 Oct |
4 |
| 83 |
19309762 | Bioanalytical methods for the determination of itraconazole and hydroxyitraconazole: overview from clinical pharmacology, pharmacokinetic, pharmacodynamic and metabolism perspectives. | 2009 Jul |
1 |
| 84 |
19954708 | 4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. | 2009 Dec |
3 |
| 85 |
20230761 | Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023. | 2009 |
1 |
| 86 |
17495874 | Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo. | 2008 Jan |
3 |
| 87 |
18218784 | Effect of itraconazole on the pharmacokinetics of imidafenacin in healthy subjects. | 2008 Mar |
1 |
| 88 |
18520601 | Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies. | 2008 Jun |
1 |
| 89 |
18783297 | General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information. | 2008 |
1 |
| 90 |
19025521 | Itraconazole, a potent inhibitor of P-glycoprotein, moderately increases plasma concentrations of oral morphine. | 2008 Nov |
1 |
| 91 |
19356088 | Effects of cyclosporine A and itraconazole on permeability, biliary excretion and pharmacokinetics of amlodipine. | 2008 Aug |
2 |
| 92 |
17003527 | Itraconazole comedication increases systemic levels of inhaled fluticasone in lung transplant recipients. | 2007 |
1 |
| 93 |
17386084 | Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models. | 2007 Mar 26 |
1 |
| 94 |
17484517 | Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. | 2007 Feb |
1 |
| 95 |
17517842 | Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents. | 2007 Aug |
1 |
| 96 |
16418697 | Effects of itraconazole and tandospirone on the pharmacokinetics of perospirone. | 2006 Feb |
2 |
| 97 |
16556082 | Drug interactions during therapy with three major groups of antimicrobial agents. | 2006 Apr |
1 |
| 98 |
16700545 | Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations. | 2006 May 23 |
4 |
| 99 |
17178259 | Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. | 2006 Dec |
1 |
| 100 |
15684493 | Identification of human P450 isoforms involved in the metabolism of the antiallergic drug, oxatomide, and its kinetic parameters and inhibition constants. | 2005 Feb |
2 |